Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Rockwell Medical, Inc. (RMTI) vs Universe Pharmaceuticals INC (UPC)

Rockwell Medical, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. is the larger, with a market value of $34.5M against $23.5M — 1.5× the size. Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −7.33%) and the higher return on invested capital (0.00% vs −14.6%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 11 and Rockwell Medical, Inc. on 4.

Valuation

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.48 n/m 2.25
P/B 0.95 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 8.52 12.29
EV/Sales 0.25 (0.24) 2.56
Earnings yield (15.95%) (30.74%) (2.99%)
Free cash flow yield (2.95%) 0.00% 0.00%

Profitability

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
Gross margin 17.71% 49.77% 53.94%
Operating margin (6.52%) 0.00% 0.00%
Net margin (7.33%) (6.42%) 0.00%
Free cash flow margin 2.47% 0.00% 0.00%
Return on equity (15.53%) 0.00% (0.40%)
Return on assets (9.32%) 0.00% (3.32%)
Return on invested capital (14.58%) 0.00% 0.00%

Growth

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (21.12%) — 10.01%
EPS growth (last fiscal year) (870.87%) 98.71% —
Revenue growth, 5-year CAGR 2.17% (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.26 0.17 0.05
Current ratio 3.25 4.05 2.31
Net debt to EBITDA 7.40 10.15 0.85

Dividend

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric RMTI UPC Drug Manufacturers Specialty & Generic median
Market cap 34.54m 23.54m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack